Literature DB >> 24146114

["In a Socialist State it Should be Possible for Activists like me to Receive Effective Medication." Psychotropic Drugs and Consumer Interests in the GDR].

Viola Balz1.   

Abstract

Entities:  

Year:  2013        PMID: 24146114     DOI: 10.1007/s00048-013-0094-0

Source DB:  PubMed          Journal:  NTM        ISSN: 0036-6978


× No keyword cloud information.
  14 in total

1.  [Possibilities of target therapy; combined reserpine-phenothiazine therapy of schizophrenia].

Authors:  H NEUMANN
Journal:  Nervenarzt       Date:  1959-06-20       Impact factor: 1.214

2.  The treatment of depressive states with G 22355 (imipramine hydrochloride).

Authors:  R KUHN
Journal:  Am J Psychiatry       Date:  1958-11       Impact factor: 18.112

3.  Activism, drug regulation, and the politics of therapeutic evaluation in the AIDS era: a case study of ddC and the 'surrogate markers' debate.

Authors:  S Epstein
Journal:  Soc Stud Sci       Date:  1997-10       Impact factor: 3.885

4.  A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer.

Authors:  H P LOOMER; J C SAUNDERS; N S KLINE
Journal:  Psychiatr Res Rep Am Psychiatr Assoc       Date:  1957-12

5.  Chlorpromazine and neuroleptic treatments in psychiatry.

Authors:  J DELAY; P DENIKER
Journal:  J Clin Exp Psychopathol       Date:  1956 Jan-Mar

6.  [Review of: Healy, David. The Creation of psychopharmacology. Cambridge, MA: Harvard University Press, 2002].

Authors:  Nathan Greenslit
Journal:  Hist Psychiatry       Date:  2004-06

7.  The history of the patient history since 1850.

Authors:  Jonathan Gillis
Journal:  Bull Hist Med       Date:  2006       Impact factor: 1.314

8.  [Effects of largactil in depressive states and manias and in withdrawal in morphine and barbiturate addiction].

Authors:  P KIELHOLZ
Journal:  Schweiz Arch Neurol Psychiatr       Date:  1954

9.  [Psychotropic drugs in socialism? Drug regulation in the German Democratic Republic in the 1960s].

Authors:  Ulrike Klöppel; Viola Balz
Journal:  Ber Wiss       Date:  2010-12       Impact factor: 0.328

10.  Pharmaceutical marketing and the invention of the medical consumer.

Authors:  Kalman Applbaum
Journal:  PLoS Med       Date:  2006-04-11       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.